Treatment Database
enzyme transport vehicle specific for the transferrin receptor fused to iduronate 2-sulfatase
Trade Name not avaiable
Orphan Indication Mucopolysaccharidosis type II
USA Market Approval
USA Designation Date 19-02-2019
Sponsor Denali Therapeutics Inc.
151 Oyster Point Blvd, Second Floor
South San Francisco, California, 94080
More about Hunter Syndrome
Free Newsletter